Improved MRI imaging for patients with hip implants
Optimized MRI of Patients With Hip Arthroplasty
This study tests a new MRI technique to see if it can provide clearer images for people with hip implants compared to the standard MRI.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 22 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Sponsor | NYU Langone Health Academic / other |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT04875884 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of a modified 3T MRI technique compared to a standard MRI in patients with total hip arthroplasty. It involves imaging twenty participants to assess the size of artifact-degraded regions, visibility of normal structures, and the detection rate of abnormalities. The study aims to determine if the modified MRI can reduce metal-related artifacts that obscure important anatomical details. Participants will undergo both imaging methods to allow for direct comparison of results.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with unilateral symptomatic total hip arthroplasty referred for an MRI.
Not a fit: Patients with a history of revision hip arthroplasty or those who are pregnant may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved MRI imaging quality for patients with hip implants, enhancing diagnosis and treatment planning.
How similar studies have performed: While similar imaging optimization studies have been conducted, this specific approach using modified MRI techniques for hip arthroplasty is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged ≥ 18 with unilateral symptomatic (e.g. pain) total hip arthroplasty * Referred for MRI examination at the discretion of the treating physician * Provision of signed and dated informed consent form * No metal hardware in the body including contralateral hip arthroplasty * No contraindication to MRI: defined as claustrophobia or presence of other MRI-incompatible devices Exclusion Criteria: * History of revision hip arthroplasty * Pregnancy (self-reported, or self-suspected) * Hip arthroplasty surgery within one year of enrollment * Clinical indication to administer intravenous contrast material during MRI
Where this trial is running
New York, New York
- NYU Langone Radiology - Center for Biomedical Imaging — New York, New York, United States (Recruiting)
Study contacts
- Principal investigator: Iman Khodarahmi, MD — NYU Langone Health
- Study coordinator: Iman Khodarahmi, MD
- Email: Iman.Khodarahmi@nyulangone.org
- Phone: 212-263-1379
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.